C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 211/42 (2006.01) A61K 9/20 (2006.01) A61K 9/22 (2006.01) A61K 9/52 (2006.01) A61K 31/135 (2006.01) A61P 25/00 (2006.01) A61P 37/00 (2006.01) A61K 9/00 (2006.01) A61K 9/16 (2006.01) A61K 9/28 (2006.01) A61K 9/50 (2006.01)
Patent
CA 2290966
Sustained release dosage forms of sertraline which release sertraline at a rate between 1 mgA/hr and 40 mgA/hr. The dosage forms may exhibit an initial delay period during which sertraline is released at a rate less than 1 mgA/hr. The present invention is further directed to an acetate salt, an L-lactate salt and an L-aspartate salt of sertraline, pharmaceutical compositions thereof and methods of using that salt for treating various conditions and disorders. The present invention is also directed to processes for preparing sertraline acetate, sertraline L-lactate and sertraline L-aspartate.
Formes posologiques de sertraline, à libération prolongée, qui libèrent la sertraline à une vitesse de 1 mgA/h et 40 mgA/h. Lesdites formes peut se caractériser par un retard initial pendant lequel la sertraline est libéré à une vitesse de moins de 1 mgA/h. L'invention concerne, de plus, un sel acétate, un sel L-lactate et un sel L-aspartate de sertraline, des compositions pharmaceutiques les contenant et des procédés d'utilisation dudit sel pour le traitement d'affections et de troubles divers. Elle se rapporte également à des procédés de préparation d'acétate de sertraline, de L-lactate de sertraline et de L-aspartate de sertraline.
Am Ende Mary Tanya
Curatolo William John
Friedman Hylar Lewis
Friesen Dwayne Thomas
Herbig Scott Max
Pfizer Inc.
Smart & Biggar
LandOfFree
Sertraline salts and sustained-release dosage forms of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sertraline salts and sustained-release dosage forms of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sertraline salts and sustained-release dosage forms of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2055985